AUTOSTEM (grant 667932), NEPHSTROM (grant 634086), VISICORT (grant 602470), STARSTEM (grant 761214) and AutoCRAT were presented at the EU-MSC2 meeting hosted by Leiden University Medical Center in The Netherlands. The meeting assembles researchers, clinicians and cell product developers working within EU-sponsored research consortia, that focus on mesenchymal stromal cell (MSC) therapy for immune-related disorders and tissue regeneration. EU-MSC2, a much-anticipated event provides excellent opportunities for networking, exploring new funding opportunities and the dissemination of results contributing to MSC knowledge-sharing, research and development.
A comprehensive EU-MSC2 meeting report prepared by Katerina Apelt, Brigitte Wieles and Melissa van Pel of LUMC was published on April 29th, 2020, by the Regenerative Medicine Network. Read their findings here.